alphaveEMCURE₹1,966.40

Emcure Pharmaceuticals Ltd.

₹ CrorePeersMANKIND ALKEM TORNTPHARM ERIS GRANULES CONCORDBIO INDGN CAPLIPOINTMcap ₹37,281 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,953.6	1,959.9	1,959.9
+ Capital Work-in-Progress	124.1	172.1	172.1
+ Goodwill	367.8	414.3	414.3
+ Other Intangibles	875.4	945.0	945.0
+ Intangibles under Development	53.3	100.6	100.6
+ Non-current Investments	19.3	19.7	19.7
+ Other Non-current Financial Assets	39.5	41.2	41.2
Non-current Financial Assets	58.8	60.9	60.9
+ Deferred Tax Assets	111.0	139.4	139.4
+ Other Non-current Assets	38.9	111.2	111.2
Total Non-current Assets	3,582.8	3,903.5	3,903.5
Current Assets
+ Inventories	1,931.8	2,397.9	2,397.9
+ Current Investments	76.0	0.0	0.0
+ Trade Receivables	2,002.2	2,562.7	2,562.7
+ Cash & Cash Equivalents	155.5	136.7	136.7
+ Other Bank Balances	9.8	10.9	10.9
+ Other Current Financial Assets	52.5	68.7	68.7
Current Financial Assets	2,296.1	2,778.9	2,778.9
+ Other Current Assets	327.9	435.3	435.3
Total Current Assets	4,649.9	5,709.0	5,709.0
Total Assets	8,232.7	9,612.5	9,612.5
Equity
+ Equity Share Capital	189.5	189.6	189.6
+ Other Equity / Reserves	4,256.7	4,760.4	4,760.4
Equity — Owners of Parent	4,446.2	4,950.0	4,950.0
+ Minority Interest	195.4	26.6	26.6
Total Equity	4,641.6	4,976.7	4,976.7
Liabilities
+ Borrowings — Non-current	189.9	252.2	252.2
+ Other Non-current Financial Liab	550.9	323.5	323.5
Non-current Financial Liabilities	740.8	575.7	575.7
+ Provisions — Non-current	47.6	42.6	42.6
+ Deferred Tax Liabilities	120.0	98.0	98.0
+ Other Non-current Liabilities	14.5	7.3	7.3
Non-current Liabilities	922.9	723.6	723.6
+ Borrowings — Current	541.8	951.9	951.9
+ Trade Payables	1,479.6	1,807.8	1,807.8
+ Other Current Financial Liab	359.5	840.8	840.8
Current Financial Liabilities	2,380.9	3,600.5	3,600.5
+ Provisions — Current	54.5	72.3	72.3
+ Current Tax Liabilities	112.3	143.0	143.0
+ Other Current Liabilities	120.6	96.5	96.5
Current Liabilities	2,668.3	3,912.2	3,912.2
Total Liabilities	3,591.2	4,635.8	4,635.8
Total Equity & Liabilities	8,232.7	9,612.5	9,612.5
Assets — additional as-filed lines
+ Current Tax Assets	94.0	96.9	96.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	32.3	91.6	91.6
+ Dues to Other Creditors — Current	1,447.3	1,716.1	1,716.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.